Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-04 Purchase | 2024-03-05 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks | 43,360 | $11.35 | $492,028 | 43,360 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-03 Exercise | 2024-07-08 08:00 am | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks | 150,000 | $3.27 | 2,473,760 (Direct) | View |
| 2024-07-03 Exercise | 2024-07-08 08:00 am | N/A 2033-05-11 | Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks | 150,000 | $0 | 2,473,760 (Direct) | View |
Ownership | 2023-07-03 4:16 pm | N/A 2033-05-11 | Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks | 0 | $0 | 2,430,400 (Direct) | View |
| 2023-05-19 Exercise | 2023-05-19 4:17 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | Sapir Alex Director | 3,750 | $0 | 3,750 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 4:45 pm | N/A 2032-05-18 | PhaseBio Pharmaceuticals Inc | PHAS | Sapir Alex Director | 21,250 | $0 | 21,250 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-04 6:14 pm | N/A 2031-06-03 | PhaseBio Pharmaceuticals Inc | PHAS | Sapir Alex Director | 14,000 | $0 | 14,000 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:39 pm | N/A 2030-06-03 | PhaseBio Pharmaceuticals Inc | PHAS | Sapir Alex Director | 4,909 | $0 | 4,909 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-14 6:50 pm | N/A 2030-02-12 | PhaseBio Pharmaceuticals Inc | PHAS | Sapir Alex Director | 32,000 | $0 | 32,000 (Direct) | View |